Trials / Conditions / Drug-resistant Tuberculosis

Drug-resistant Tuberculosis

17 registered clinical trials studyying Drug-resistant Tuberculosis — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Therapeutic Drug Monitoring for Linezolid in the Treatment of Rifampin-resistant Tuberculosis NCT06590428	Albert Einstein College of Medicine	N/A
Not Yet Recruiting	Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BLMZ Chinese C NCT07268664	Beijing Chest Hospital	Phase 3
Active Not Recruiting	Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BDLL Chinese C NCT06649721	Huashan Hospital	Phase 3
Recruiting	Pragmatic Use of Next-generation Sequencing for Management of Drug-resistant Tuberculosis NCT05553236	University of California, San Francisco	N/A
Unknown	Clinical Study of JDB0131 Benzenesulfonate Tablets in Patients With Drug-sensitive Pulmonary Tuberculosis NCT06224036	Beijing Chest Hospital	Phase 2
Recruiting	Bring BPaL2Me Trial Comparing Nurse-Led RR-TB Treatment to Physician-Led RR-TB Treatment NCT05671718	Johns Hopkins University	N/A
Completed	A Phase 1, Drug-Drug Interaction Study of TBAJ-876 in Healthy Adults NCT05526911	Global Alliance for TB Drug Development	Phase 1
Completed	Triage Test for All Oral DR-TB Regimen (TRiAD Study) NCT05175794	Centre for the AIDS Programme of Research in South Africa	—
Unknown	Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment Trial NCT05017324	Universiteit Antwerpen	N/A
Completed	A Trial to Evaluate the Male Reproductive Safety of Pretomanid in Adult Male Participants With Drug Resistant NCT04179500	Global Alliance for TB Drug Development	Phase 2
Completed	Evaluate Safety, Tolerability, PK of TBAJ-876 in Healthy Adults NCT04493671	Global Alliance for TB Drug Development	Phase 1
Completed	Evaluation of Centralised TB Assay Solutions NCT04147676	Foundation for Innovative New Diagnostics, Switzerland	—
Completed	Trial to Evaluate the Efficacy, Safety and Tolerability of BPaMZ in Drug-Sensitive (DS-TB) Adult Patients and NCT03338621	Global Alliance for TB Drug Development	Phase 2 / Phase 3
Completed	Behavior Change and Digital Health Interventions for Improved TB Treatment Outcomes NCT04119375	Massachusetts Institute of Technology	N/A
Completed	An Evaluation of Traditional Directly Observed Therapy (DOT) and Electronic DOT for TB Treatment NCT03266003	Centers for Disease Control and Prevention	N/A
Completed	Brief Bactericidal Activity of Anti-Tuberculosis Drugs NCT02236078	Centers for Disease Control and Prevention	Phase 1
Completed	Rewards for Tuberculosis Contact Screening NCT02234908	Boston University	N/A